We are live on ! Find out more
TCRT icon

Alaunos Therapeutics

154 hedge funds and large institutions have $328M invested in Alaunos Therapeutics in 2016 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $24.1M | Put options by funds: $13.4M

68% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 34

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

8% more funds holding

Funds holding: 143154 (+11)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

20% less capital invested

Capital invested by funds: $408M → $328M (-$80.2M)

Holders
154
Holders Change
+11
Holders Change %
+7.69%
% of All Funds
4.11%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
31
Increased
57
Reduced
34
Closed
20
Calls
$24.1M
Puts
$13.4M
Net Calls
+$10.6M
Net Calls Change
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$2.48M +$344K +316 +12%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$2.09M -$474K -435 -15%
GC
28
Guggenheim Capital
Illinois
$1.73M +$76.2K +70 +3%
CB
29
Commerce Bank
Missouri
$1.67M
Millennium Management
30
Millennium Management
New York
$1.52M +$2.01M +1,850 New
LCM
31
Landscape Capital Management
New Jersey
$1.45M -$2.14M -1,962 -53%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$1.4M +$87.1K +80 +5%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.3M -$54.4K -50 -3%
Brown Advisory
34
Brown Advisory
Maryland
$1.17M +$1.54M +1,416 New
TA
35
Teachers Advisors
New York
$1.07M +$188K +173 +15%
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.07M
RJFSA
37
Raymond James Financial Services Advisors
Florida
$1.05M -$7.62K -7 -0.5%
Swiss National Bank
38
Swiss National Bank
Switzerland
$991K -$105K -96 -7%
HCM
39
Highbridge Capital Management
New York
$976K +$927K +851 +255%
BA
40
BlackRock Advisors
Delaware
$865K +$29.4K +27 +3%
Wells Fargo
41
Wells Fargo
California
$849K +$144K +132 +15%
ARTA
42
A.R.T. Advisors
New York
$792K -$647K -594 -38%
Goldman Sachs
43
Goldman Sachs
New York
$770K -$210K -193 -17%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$749K +$124K +114 +14%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$747K -$4.36K -4 -0.4%
Bank of America
46
Bank of America
North Carolina
$671K +$130K +119 +17%
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$648K +$3.27K +3 +0.4%
CS
48
Credit Suisse
Switzerland
$624K -$625K -574 -43%
VIA
49
Vident Investment Advisory
Georgia
$616K -$266K -244 -25%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$606K

TCRT Hedge Fund Activity: Q2 2016 in Review

154 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2016, worth a combined $328M — down 20% from $408M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TCRT positions and 20 closed out — a net gain of 11 holders — while 57 added to existing stakes and 34 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $14.2M. The largest seller was Miller Value Partners, cutting an estimated $3.36M.

  • 154 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2016, up from 143 in Q1 2016.
  • Funds reported $328M of Alaunos Therapeutics stock for Q2 2016, down 20% quarter-over-quarter.
  • 31 funds opened new Alaunos Therapeutics positions in Q2 2016 and 20 closed out, a net change of +11 holders.
  • The largest Alaunos Therapeutics buyer in Q2 2016 was Fidelity Investments, an estimated $14.2M added.
  • The largest Alaunos Therapeutics seller in Q2 2016 was Miller Value Partners, an estimated $3.36M sold.

Based on aggregated 13F filings for Q2 2016.